Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma |
Shi, Huazheng
(Shanghai Universal Medical Imaging Diagnostic Center)
Yuan, Zuguo (Department of Chemoradiotherapy, Yinzhou People's Hospital) Yuan, Zheng (Shanghai Universal Medical Imaging Diagnostic Center) Yang, Chunshan (Shanghai Universal Medical Imaging Diagnostic Center) Zhang, Jian (Shanghai Universal Medical Imaging Diagnostic Center) Shou, Yi (Shanghai Universal Medical Imaging Diagnostic Center) Zhang, Wenrui (Shanghai Universal Medical Imaging Diagnostic Center) Ping, Zhaofu (Shanghai Universal Medical Imaging Diagnostic Center) Gao, Xin (Shanghai Universal Medical Imaging Diagnostic Center) Liu, Shiyuan (Department of Radiology, affiliated Changzheng Hospital, The Second Military Medical University) |
1 | Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115:1074-1078 DOI |
2 | Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24:721-728 DOI |
3 | Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000;29:187-203 DOI |
4 | Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 2012;97:3866-3875 DOI |
5 | Makis W, Ciarallo A. Thyroid incidentalomas on 18F-FDG PET/ CT: clinical significance and controversies. Mol Imaging Radionucl Ther 2017;26:93-100 DOI |
6 | Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47:609-615 |
7 |
Ho TY, Liou MJ, Lin KJ, Yen TC. Prevalence and significance of thyroid uptake detected by |
8 | Kim H, Kim SJ, Kim IJ, Kim K. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study. Onkologie 2013;36:260-264 |
9 | Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-164 DOI |
10 | Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009;70:382-392 DOI |
11 | Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005;25:1421-1426 |
12 |
Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by |
13 | Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48:896-901 DOI |
14 | Liu Y. Clinical significance of thyroid uptake on F18- fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2009;23:17-23 DOI |
15 | Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 2007;14:239-247 |
16 | I HS, Kim SJ, Kim IJ, Kim K. Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer. Clin Nucl Med 2012;37:442-446 DOI |
17 | Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100-4104 DOI |
18 | Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007;28:373-381 DOI |
19 | Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med 2012;53:709-715 DOI |
20 | Erdi YE, Macapinlac H, Rosenzweig KE, Humm JL, Larson SM, Erdi AK, et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 2000;27:861-866 DOI |
21 | Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging 2013;40:290-301 DOI |
22 | Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, et al. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed Pharmacother 2007;61:488-493 DOI |
23 | Kim D, Hwang SH, Cha J, Jo K, Lee N, Yun M. Risk stratification of thyroid incidentalomas found on PET/CT: the value of iodine content on noncontrast computed tomography. Thyroid 2015;25:1249-1254 DOI |
24 | Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001;130:941-946 DOI |
25 | Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Nucl Med Commun 2013;34:868-876 |
26 | Kim SJ, Chang S. Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results. Endocrine 2015;50:681-688 DOI |
27 | Nam SY, Roh JL, Kim JS, Lee JH, Choi SH, Kim SY. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf) 2007;67:135-139 DOI |
28 |
Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen- Auerbach M, et al. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an |
29 | Lee S, Park T, Park S, Pahk K, Rhee S, Cho J, et al. The clinical role of dual-time-point (18)F-FDG PET/CT in differential diagnosis of the thyroid incidentaloma. Nucl Med Mol Imaging 2014;48:121-129 DOI |
![]() |